We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Analysis

Executive Summary

A New IQVIA Institute report shows that rebates, discounts and limits on access to medicines are having the effect that payers want: drug spending growth is slowing and will soon plateau, even as new, high-cost brands come to market. PhRMA's view? Competitive markets keep costs down.